Skip to main content
SpringerLink
Log in

A Biological, Environmental, and Cultural Basis for Ethnic Differences in Treatment

  • Chapter
Handbook of Diversity Issues in Health Psychology

Part of the book series: The Plenum Series in Culture and Health ((PSCH))

Abstract

During the past half century, progress in pharmacotherapy has led to effective therapeutic regimens for a wide variety of medical conditions. At the same time, clinicians have become increasingly sophisticated at using Pharmaceuticals and in minimizing their adverse side effects. Modern clinical pharmacology, however, has been based largely on research and clinical experiences with Caucasian patients and subjects. Relatively little is known about applying pharmacotherapy to ethnic minority populations in this country and to non-Western populations worldwide (Lawson, 1986), even though non-Caucasians comprise fully 25% of the U.S. population. According to the 1990 census, 12% of the U.S. population is African-American, 9% Hispanic-American, 3% Asian-American, and 1% Native Americans. These percentages are higher than in previous census reports and are expected to continue growing (Bureau of the Census, 1990).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Agarwal, D., & Goedde, H. (1990). Alcohol metabolism, alcohol intolerance and alcoholism: Biochemical and pharmacogenetic approaches. Berlin: Springer-Verlag.

    Google Scholar 

  • Ahsan, C., Renwick, A., Waller, D., Challenor, V., George, C., & Amanullah, M. (1993). The influences of dose and ethnic origins on the pharmacokinetics of nifedipine. Clinical Pharmacology and Therapeutics, 54, 329–338.

    Article  PubMed  Google Scholar 

  • Angenent, W., & Koelle, G. (1953). A possible enzymatic basis for the differential action of mydriatics on light and dark irises. Journal of Physiology, 119, 102–117.

    Google Scholar 

  • Baumann, P., & Eap, C. (1988). Alpha-acid glycoprotein genetics, biochemistry, physiological Junctions and pharmacology. New York: Alan R. Liss.

    Google Scholar 

  • Baumann, P., & Eap, C. (1991). Plasma monitoring of antidepressants: clinical relevance of the pharmacogenetics of metabolism and of acid glycoprotein binding. Biological Psychiatry, 29, 75–95.

    Google Scholar 

  • Bertilsson, L., & Aberg-Wistedt, A. (1983). The debrisoquine hydroxylation test predicts steady-state plasma levels of desipramine. British Journal of Clinical Pharmacology, 15, 388–390.

    PubMed  Google Scholar 

  • Bertilsson, L., Eichelbaum, M., & Mellstrom, B. (1980). Nortriptyline and antipyrine clearance in relation to debrisoquine hydroxylation in man. Life Sciences, 27, 1673–1677.

    Article  PubMed  Google Scholar 

  • Branch, R., Salih, S., & Homeida, M. (1978). Racial differences in drug metabolizing ability. A study with antipyrine in the Sudan. Clinical Pharmacology and Therapeutics, 24, 283–286.

    PubMed  Google Scholar 

  • Bureau of the Census. (1990). Statistical abstracts of the United States: 1990 (110th ed.). Washington, DC: Author.

    Google Scholar 

  • Chang, W. H., Chen, T. Y., Lee, C. F., Hu, W. H., & Yeh, E. K. (1987). Low plasma reduced haloperidol/haloperidol ratios in Chinese patients. Biological Psychiatry, 22, 1406–1408.

    Article  PubMed  Google Scholar 

  • Chang, S., Pandey, G., Yang, Y., Yeh, E., & Davis, J. (1985). Lithium pharmacokinetics: Interracial comparison. Paper presented at the 138th Annual Meeting of the American Psychiatric Association, Dallas, TX.

    Google Scholar 

  • Chen, K. K., & Poth, E. J. (1927). The racial difference of the mydriatic action of ephedrine, cocaine, and euphthalmine. Proceedings of the Society for Experimental Biology and Medicine, 25, 150–151.

    Google Scholar 

  • Clark, W., Brater, D., & Johnson, A. (1988). Goth’s Medical Pharmacology (12th ed.). St. Louis: C. V. Mosby.

    Google Scholar 

  • Crabtree, B., Jann, M., & Pitts, W. (1991). Alpha acid glycoprotein levels in patients with schizophrenia: Effect of treatment with haloperidol. Biological Psychiatry, 29, 18A–43A.

    Google Scholar 

  • Dahl-Puustinen, M. L., Liden, A., & Aim, C. (1989). Disposition of perphenazine is related to polymorphic debrisoquine hydroxylation in human beings. Clinical Pharmacology and Therapeutics, 46, 78–81.

    Article  PubMed  Google Scholar 

  • Desai, N. K., Sheth, U. K., & Mucklow, J. C. (1980). Antipyrine clearance in Indian villagers. British Journal of Clinical Pharmacology, 9, 387–394.

    PubMed  Google Scholar 

  • Dimsdale, J., Zeigler, M., and Graham, R. (1988). The effect of hypertension, sodium, and race on isoproterenol sensitivity. Clinical and Experimental Hypertension: Theory and Practice, A10, 747–756.

    Google Scholar 

  • Dollery, C., Fraser, H., & Mucklow, J. (1979). Contribution of environmental factors to variability in human drug metabolism. Drug Metabolism Review, 9, 207–220.

    Google Scholar 

  • Du, Y., & Lou, Y. (1990). Polymorphism of debrisoquine 4-hydroxylation and family studies of poor metabolizers in Chinese population. Acta Pharmacologica Sinica, 11, 7–10.

    PubMed  Google Scholar 

  • Dufour, A. P., Knight, R. A., & Harris, H. W. (1964). Genetics of isoniazid metabolism in Caucasians, Negroes, and Japanese populations. Science, 145, 391.

    Article  PubMed  Google Scholar 

  • Fleishaker, J., Smith, T., Friedman, H., & Hulst, L. (1992). Separation of the pharmacokinetic/pharmacodynamic properties of oral and IV adinazolam mesylate and N-de-smethyladinazolam mesylate in health volunteers. Drug Investigations, 4, 155–165.

    Google Scholar 

  • Fraser, H., Mucklow, J., Bulpitt, C., Kahn, C., Mould, G., & Dollery, C. (1979). Environmental factors affecting antipyrine metabolism in London factory and office workers. British Journal of Clinical Pharmacology, 7, 237–243.

    PubMed  Google Scholar 

  • Fukuma, Y., Kashimimura, S., Umetsu, K., Yuasa, I., & Suzuki, T. (1990). Genetic variation of alpha-2-HS-glycoprotein in the Kyushu district of Japan: Description of three new rare variants. Human Heredity, 40, 49–51.

    PubMed  Google Scholar 

  • Garde, J., Aston, R., Endler, G., & Sison, O. (1978). Racial mydriatic response to belladonna premedication. Anesthesia and Analgesia, 57, 572–576.

    PubMed  Google Scholar 

  • Ghoneim, M., Korttila, K., Chiang, C., Jacobs, L., Schoenwald, R., Newaldt, S., & Lauaba, K. (1981). Diazepam effects and kinetics in Caucasians and Orientals. Clinical Pharmacology and Therapeutics, 29, 749–746.

    Article  PubMed  Google Scholar 

  • Gonzalez, F. (1989). The molecular biology of cytochrome P450s. Pharmacological Reviews, 40, 243–288.

    Google Scholar 

  • Gonzalez, F., & Nebert, D. (1990). Evolution of the P450 gene superfamily: Animal-plant “warfare,” molecular drive, and human genetic differences in drug oxidation. Trends in Genetics, 6, 182–186.

    Article  PubMed  Google Scholar 

  • Goodman, C., Rosendorff, C., & Gould, A. (1985). Comparison of the antihypertensive effect of enalipril and propanalol in black South Africans. South African Medical Journal, 67, 672–6.

    PubMed  Google Scholar 

  • Grant, D., Morike, K., & Eichelbaum, M. (1990). Acetylation pharmacogenetics. Journal of Clinical Investigation, 85, 968–972.

    Article  PubMed  Google Scholar 

  • Grant, D., Tand, B., & Kalow, W. (1984). A simple test for acetylator phenotype using caffeine. British Journal of Clinical Pharmacology, 17, 459–464.

    PubMed  Google Scholar 

  • Hall, D. H. (1990). Pathophysiology of hypertension in blacks. American Journal of Hypertension, 3, 366S–371S.

    PubMed  Google Scholar 

  • Horai, Y., Taga, J., Ishizaki, T., & Ishikawa, K. (1990). Correlations among the metabolic ratios of three test probes (metoprolol, debrisoquine, sparteine) for genetically determined oxidation polymorphism in a Japanese population. British Journal of Clinical Pharmacology, 29, 111–115.

    PubMed  Google Scholar 

  • Hu, W., Lee, C., Yang, Y., & Tseng, Y. (1983). Imipramine plasma levels and clinical response. Bulletin of Chinese Society of Neurology and Psychiatry, 9, 40–49.

    Google Scholar 

  • Inaba, T., & Arias, T. D. (1987). On phenotyping with isoniazid: The use of urinary acetylation ratio and the uniqueness of antimodes. Study of two Amerindian populations. Clinical Pharmacology and Therapeutics, 42, 493–497.

    Article  PubMed  Google Scholar 

  • Ishizaki, T., Eichelbaum, M., & Horai, Y. (1987). Evidence for polymorphic oxidation of sparteine in Japanese subjects. British Journal of Clinical Pharmacology, 23, 482–485.

    PubMed  Google Scholar 

  • Islam, S. I., Idle, J. R., & Smith, R. L. (1980). The polymorphic 4-hydroxylation of debrisoquine in a Saudi Arab population. Xenobiotica, 10, 819–825.

    PubMed  Google Scholar 

  • Jann, M., Chang, W., Davis, C., Chen, T., Deng, H., Lung, F., Ereshefsky, L., Saklad, S., & Richards, A. (1989). Haloperidol and reduced haloperidol plasma levels in Chinese vs. non-Chinese psychiatric patients. Psychiatry Research, 30, 45–52.

    Article  PubMed  Google Scholar 

  • Jann, M., Lam, Y., & Chang, W. (1993). Haloperidol and reduced haloperidol plasma concentrations in different ethnic populations and interindividual variabilities in haloperidol metabolism. In K. Lin, R. Poland, & G. Nakasaki (Eds.), Psychopharmacology and psychobiology of ethnicity (pp. 133–152). Washington, DC: American Psychiatric Press.

    Google Scholar 

  • Jones, B., & Runikis, A. (1987). Interaction of ginseng with phenelzine. Journal of Clinical Psychopharmacology, 201–202.

    Google Scholar 

  • Jorge, L. F., Arias, T. D., Inaba, T., & Jackson, P. R. (1990). Unimodal distribution of the metabolic ratio for debrisoquine in Cuna Amerindians of Panama. British Journal of Clinical Pharmacology, 30, 281–285.

    PubMed  Google Scholar 

  • Juneja, R., Weitkamp, L., & Straitil, A. (1988). Further studies of the plasma, Alpha B-glycoprotein polymorphism: Two new alleles and allele frequencies in Caucasians and in American Blacks. Human Heredity, 38, 267–272.

    PubMed  Google Scholar 

  • Kalow, W. (1989). Race and therapeutic drug response. New England Journal of Medicine, 320, 588–589.

    Article  PubMed  Google Scholar 

  • Kalow, W. (1991). Interethnic variation of drug metabolism. Trends in Pharmacological Science, 12, 102–107.

    Article  Google Scholar 

  • Kalow, W. (Ed.). (1992). Pharmacogenetics of Drug Metabolism. New York: Pergamon Press.

    Google Scholar 

  • Kalow, W. (1993). Pharmacogenetics: Its biologic roots and the medical challenge. Clinical Pharmacology and Therapeutics, 54, 235–241.

    Article  PubMed  Google Scholar 

  • Kleinman, A. (1980). Patients and healers in the context of culture. Berkeley: University of California.

    Google Scholar 

  • Kremer, J., Wilting, J., & Janssen, L. (1988). Drug binding to human alpha-1-acid glycoprotein in health and disease. Pharmacological Review, 40, 1–45.

    Google Scholar 

  • Kumana, C., Lauder, I., Chan, M., Ko, W., & Lin, H. (1987). Differences in diazepam pharmacokinetics in Chinese and white Caucasians: Relation to body lipid stores. European Journal of Clinical Pharmacology, 32, 211–215.

    Article  PubMed  Google Scholar 

  • Kupfer, A., & Preisig, R. (1984). Pharmacogenetics of mephenytoin: A new drug hydroxylation polymorphism in man. European Journal of Clinical Pharmacology, 26, 753–759.

    Article  PubMed  Google Scholar 

  • Lawson, W. (1986). Racial and ethnic factors in psychiatric research. Hospital and Community Psychiatry, 37, 50–54.

    PubMed  Google Scholar 

  • Lee, E. J., Nam, Y. P., & Hee, G. N. (1988). Oxidation phenotyping in Chinese and Malay populations. Clinical and Experimental Pharmacology and Physiology, 15, 889–891.

    Article  PubMed  Google Scholar 

  • Lee, S. (1993). Side effects of chronic lithium therapy in Hong Kong Chinese: An ethnopsychiatric perspective. Culture, Medicine, and Psychiatry, 17, 301–320.

    Article  Google Scholar 

  • Levy, R., & Moreland, T. (1984). Rationale for monitoring free drug levels. Clinical Pharmacokinetics (Suppl I), 1–9.

    Google Scholar 

  • Lin, K., Lau, J., Smith, R., & Poland, R. (1988a). Comparison of alprazolam plasma levels and behavioral effects in normal Asian and Caucasian male volunteers. Psychopharmacology, 96, 365–369.

    Article  PubMed  Google Scholar 

  • Lin, K., Poland, R., Lau, J., & Rubin, R. (1988b). Haloperidol and prolactin concentrations in Asians and Caucasians. Journal of Clinical Psychopharmacology, 8, 195–201.

    Article  PubMed  Google Scholar 

  • Lin, K., Poland, R., & Nakasaki, G. (Eds.). (1993). Psychopharmacology and psychobiology of ethnicity. Washington, DC: American Psychiatric Press.

    Google Scholar 

  • Lin, K., Poland, R., Nuccio, I., Matsuda, K., Hathuc, N., Su, T., & Fu, P. (1989). Longitudinal assessment of haloperidol dosage and serum concentration in Asian and Caucasian schizophrenic patients. American Journal of Psychiatry, 146, 1307–1311.

    PubMed  Google Scholar 

  • Lin, K., & Shen, W. (1991). Pharmacotherapy for southeast Asian psychiatric patients. Journal of Nervous and Mental Disease, 179, 346–50.

    Article  PubMed  Google Scholar 

  • Liu, G. (1991). Effects of some compounds isolated from Chinese medicinal herbs on hepatic microsomal cytochrome P-450 and their potential biological consequences. Drug Metabolism Review, 23, 439–465.

    Google Scholar 

  • Lou, Y., Ying, L., Bertilsson, L., & Sjoqvist. (1987). Low frequency of slow debrisoquine hydroxylation in a native Chinese population. Clinical Pharmacology and Therapeutics, 15, 443–450.

    Google Scholar 

  • Mahgoub, A., Idle, J. R., & Smith, R. L. (1979). A population and familial study of the defective alicyclic hydroxylation of debrisoquine among Egyptians. Xenobiotica, 9, 51–56.

    Article  PubMed  Google Scholar 

  • Mellstrom, B., Bertilsson, L., & Lou, Y. C. (1983). Amitriptyline metabolism: Relationship to polymorphic debrisoquine hydroxylation. Clinical Pharmacology and Therapeutics, 34, 516–520.

    Article  PubMed  Google Scholar 

  • Mendoza, R., Smith, M., Poland, R., Lin, K., & Strickland, T. (1991). Ethnic psychopharmacology: The Hispanic and Native American perspective. Psychopharmacology Bulletin, 27, 449–461.

    PubMed  Google Scholar 

  • Meyer, U. (1990). Genetic polymorphisms of drug metabolism. Fundamental and Clinical Pharmacology, 4, 595–616.

    Article  PubMed  Google Scholar 

  • Meyer, U. (1992). Molecular genetics and the future of pharmacogenetics. In W. Kalow (Ed.), Pharmacogenetics of Drug Metabolism (pp. 879–888). New York: Pergamon Press.

    Google Scholar 

  • Midha, K., Hawes, E., Hubbard, J., Korchinski, E., & McKay, G. (1988a). A pharmacokinetic study of trifluoperazine in two ethnic populations. Psychopharmacology, 95, 333–338.

    Article  PubMed  Google Scholar 

  • Midha, K., Hawes, E., Hubbard, J., Korchinski, E., & McKay, G. (1988b). Variation in the single dose pharmacokinetics of fluphenazine in psychiatric patients. Psychopharmacology, 96, 206–211.

    Article  PubMed  Google Scholar 

  • Moerman, D. (1979). Anthropology of symbolic healing. Currents in Anthropology, 20, 59–80.

    Article  Google Scholar 

  • Moser, M., & Lunn, J. (1981). Comparative effects of pindolol and hydrochlorothiazide in black hypertensive patients. Angiology, 32, 561–566.

    PubMed  Google Scholar 

  • Murray, M., & Reidy, G. (1990). Selectivity in the inhibition of mammalian cytochromes P-450 by chemical agents. Pharmacology Review, 42, 85–101.

    Google Scholar 

  • Nakamura, K., Goto, F., & Ray, W. A. (1985). Interethnic differences in genetic polymorphism of debrisoquine and mephenytoin hydroxylation between Japanese and Caucasian populations. Clinical Pharmacology and Therapeutics, 38, 402–408.

    Article  PubMed  Google Scholar 

  • Okey, A. (1992). Enzyme induction in the cytochrome P-450 system. New York: Pergamon Press.

    Google Scholar 

  • Potkin, S., Shen, Y., Pardes, H., Phelps, B., Zhou, D., Shu, L., Korpi, E., & Wyatt, R. (1984). Haloperidol concentrations elevated in Chinese patients. Psychiatry Research, 12, 167–172.

    Article  PubMed  Google Scholar 

  • Reidenberg, M., & Erill, S. (1986). Drug-protein binding. New York: Oxford University Press.

    Google Scholar 

  • Rieder, M. J., Shear, N. H., Kanee, A., Tang, B. K., & Spielberg, S. P. (1991). Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions. Clinical Pharmacology and Therapeutics, 49, 13–17.

    Article  PubMed  Google Scholar 

  • Rosenblat, R., & Tang, S. (1987). Do Oriental psychiatric patients receive different dosages of psychotropic medication when compared with Occidentals? Canadian Journal of Psychiatry, 32, 270–274.

    Google Scholar 

  • Routledge, P. (1986). The plasma protein binding of basic drugs. British Journal of Clinical Pharmacology, 22, 499–506.

    PubMed  Google Scholar 

  • Rutledge, D., Steinberg, M., & Cardozo, L. (1989). Racial differences in drug response: Isoproterenol effects on heart rate following intervenous metoprolol. Clinical Pharmacology and Therapeutics, 45, 380–386.

    Article  PubMed  Google Scholar 

  • Sackett, D., & Haynes, R. (1976). Compliance with therapeutic regimens. Baltimore: The Johns Hopkins Press.

    Google Scholar 

  • Shader, R., & Greenblatt, D. (1988). Bees, ginseng and MAOI’s revisited. Journal of Clinical Psychopharmacology, 8, 325.

    Google Scholar 

  • Shaheen, O., Biollaz, J., & Koshakji, R. P. (1989). Influence of debrisoquine phenotype on the inducibility of propranolol metabolism. Clinical Pharmacology and Therapeutics, 45, 439–443.

    Article  PubMed  Google Scholar 

  • Shen, W., & Lin, K. (1990). Cytochrome P-450 monooxygenases and interactions of psycho-tropic drugs. International Journal of Psychiatry in Medicine, 21, 21–30.

    Google Scholar 

  • Shibuya, A., & Yoshida, A. (1988). Frequency of the atypical aldehyde dehydrogenase-2 gene (ALDH2/2) in Japanese and Caucasians. American Journal of Human Genetics, 43, 744–748.

    PubMed  Google Scholar 

  • Silver, B., Poland, R., & Lin, K. (1993). Ethnicity and the pharmacology of tricyclic anti-depressants. In K. Lin, R. Poland, & G. Nakasaki (Eds.), Psychopharmacology and psychobiology of ethnicity (pp. 61–89). Washington, DC: American Psychiatric Press.

    Google Scholar 

  • Skjelbo, E., Brosen, K., Hallas, J., & Gram, L. (1991). The mephenytoin oxidation polymorphism is partially responsible for the N-demethylation of imipramine. Clinical Pharmacology and Therapeutics, 49, 18–23.

    Article  PubMed  Google Scholar 

  • Smith, M., Lin, K., & Mendoza, R. (1993). “Non-biological” issues affecting psychopharmacotherapy: Cultural considerations. In K. Lin, R. Poland, & G. Nakasaki (Eds.), Psychopharmacology and psychobiology of ethnicity (pp. 37–58). Washington, DC: American Psychiatric Press.

    Google Scholar 

  • Stein, M., O’Malley, K., & Kilfeather, S. (1990). Ethnic differences in cyclic AMP accumulation: Effect on alpha, beta, and prostanoid receptor responses. Clinical Pharmacology and Therapeutics, 47, 360–365.

    Article  PubMed  Google Scholar 

  • Takahashi, R. (1979). Lithium treatment in affective disorders: Therapeutic plasma level. Psychopharmacology Bulletin, 15, 32–35.

    PubMed  Google Scholar 

  • Umetsu, K., Yuasa, I., & Nishimura, H. (1988). Genetic polymorphisms of orosomucoid and alpha-2-HS-glycoprotein in a Philippine population. Human Heredity, 38, 287–290.

    PubMed  Google Scholar 

  • Venter, C. P., Daya, S., Joubert, P. H., & Strydom, W. J. (1985). Ethnic differences in human lymphocytic cyclic AMP production after isoprenaline stimulation and propranolol blockade. British Journal of Clinical Pharmacology, 19, 187–190.

    PubMed  Google Scholar 

  • Wanwimolruk, S., Patamasucon, P., & Lee, E. J. D. (1990). Evidence for the polymorphic oxidation of debrisoquine in the Thai population. British Journal of Pharmacology, 29, 244–247.

    Google Scholar 

  • Ward, S., Walle, T., & Walle, U. (1989). Propranolol’s metabolism is determined by both mephenytoin and debrisoquin hydroxylase activities. Clinical Pharmacology and Therapeutics, 45, 75–79.

    Google Scholar 

  • Weber, W. W. (1987). The acetylator genes and drug responses. New York: Oxford University Press.

    Google Scholar 

  • Wilkinson, G. R., Guengerich, F. P., & Branch, R. A. (1989). Genetic polymorphism of S-mephenytoin hydroxylation. Clinical Pharmacology and Therapeutics, 43, 53–76.

    Google Scholar 

  • Wood, A., & Zhou, H. (1991). Ethnic differences in drug disposition and responsiveness. Clinical Pharmacokinetics, 20, 1–24.

    Google Scholar 

  • Xu, X., & Jiang, W. (1990). Debrisoquine hydroxylation and sulfamethazine acetylation in a Chinese population. Acta Pharmacologica Sinica, 11, 387–388.

    Google Scholar 

  • Yamamoto, J., Yeh, E. K., Le, C. K., & Lin, K. M. (1988). Alcohol abuse among Koreans and Taiwanese. In L. Towle & T. Harford (Eds.), Cultural influences and drinking patterns: A focus in Hispanic and Japanese populations (Research Monograph No. 19). Rockville, MD: National Institute on Alcohol Abuse and Alcoholism.

    Google Scholar 

  • Yamashita, I., & Asano, Y. (1979). Tricyclic antidepressants: Therapeutic plasma level. Psychopharmacology Bulletin, 15, 40–41.

    PubMed  Google Scholar 

  • Yoshida, A. (1983). Differences in the isozymes involved in alcohol metabolism between Caucasians and Orientals. New York: Alan R. Liss.

    Google Scholar 

  • Yue, Q. Y., Bertilsson, L., Dahl-Puustinen, M. L., Sawe, J., Sjoqvist, F., Johansson, I., & Ingelman-Sundberg, M. (1989a). Disassociation between debrisoquine hydroxylation phenotype and genotype among Chinese. Lancet, 2, 870.

    Article  PubMed  Google Scholar 

  • Yue, Q. Y., Hasselstrom, J., Sevensson, J. O. & Sawe, J. (1991a). Pharmacokinetics of codeine and its metabolites in Caucasian healthy volunteers: Comparisons between extensive and poor hydroxylators of debrisoquine. British Journal of Clinical Pharmacology, 31, 635–642.

    PubMed  Google Scholar 

  • Yue, Q. Y., Svensson, J. O., Aim, C., Sjoqvist, F., & Sawe, J. (1989b). Interindividual and interethnic differences in the demethylation and glucuronidation of codeine. British Journal of Clinical Pharmacology, 28, 629–637.

    PubMed  Google Scholar 

  • Yue, Q. Y., Svensson, J. O., Sjoqvist, F., & Sawe, J. (1991b). A comparison of the pharmacokinetics of codeine and its metabolites in healthy Chinese and Caucasian extensive hydroxylators of debrisoquine. British Journal of Clinical Pharmacology, 31, 643–647.

    PubMed  Google Scholar 

  • Yue, Q. Y., VanBahr, C., Odar-Cederlof, I., & Sawe, J. (1990). Glucuronidation of codeine and morphine in human liver and kidney microsomes: Effect of inhibitors. Pharmacology and Toxicology, 66, 221–226.

    Article  PubMed  Google Scholar 

  • Zhang, Y., Reviriego, J., Lou, Y., Sjoqvist, F., & Bertilsson, L. (1990). Diazepam metabolism in native Chinese poor and extensive hydroxylators of S-mephenytoin: interethnic differences in comparison with white subjects. Clinical Pharmacology and Therapeutics, 48, 496–502.

    Article  PubMed  Google Scholar 

  • Zhou, H., Koshakji, R., Siolberstein, D., Wilkinson, G., & Wood, A. (1989). Altered sensitivity to and clearance of propranolol in men of Chinses descent as compared with American white. New England Journal of Medicine, 320, 565–570.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Center on the Psychobiology of Ethnicity, Harbor-UCLA Research and Education Institute, Torrance, California, 90502

    Michael Smith & Keh-Ming Lin

Authors
  1. Michael Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Keh-Ming Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Stanford University, Stanford, California

    Pamela M. Kato  & Traci Mann  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Plenum Press, New York

About this chapter

Cite this chapter

Smith, M., Lin, KM. (1996). A Biological, Environmental, and Cultural Basis for Ethnic Differences in Treatment. In: Kato, P.M., Mann, T. (eds) Handbook of Diversity Issues in Health Psychology. The Plenum Series in Culture and Health. Springer, Boston, MA. https://doi.org/10.1007/978-0-585-27572-7_20

Download citation

  • DOI: https://doi.org/10.1007/978-0-585-27572-7_20

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-45325-0

  • Online ISBN: 978-0-585-27572-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation